| 수집원 | 발생값 ↑ | 관측 가능 시각 | 법인 | 회사명 | 사업연도 | 기간 | 연결구분 | 재무제표 | 계정명 | 표준 지표 | 금액 | 기준일 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | IS | 당기순이익(손실) | net_income | 7347.2억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:15 | — | 한국전력공사 | 2,025 | Q3 | CFS | BS | 유동자산 | current_assets | 31.8조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | Q3 | OFS | BS | 유동부채 | current_liabilities | 2.7조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | IS | 매출액 | revenue | 3.1조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | Q3 | OFS | BS | 비유동부채 | non_current_liabilities | 1.2조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 자본총계 | total_equity | 28.7조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | Q3 | OFS | BS | 자산총계 | total_assets | 14.4조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | Q3 | OFS | BS | 부채총계 | total_liabilities | 4조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | Q3 | OFS | BS | 자본금 | capital_stock | 1779.3억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 이익잉여금 | retained_earnings | 27.2조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 자본금 | capital_stock | 164.8억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 부채총계 | total_liabilities | 11.9조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 비유동부채 | non_current_liabilities | 3.9조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:54 | — | 삼성전자 | 2,025 | Q3 | OFS | BS | 자산총계 | total_assets | 325.4조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | Q3 | OFS | BS | 이익잉여금 | retained_earnings | 4.5조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 유동부채 | current_liabilities | 8조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 자산총계 | total_assets | 40.7조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 비유동자산 | non_current_assets | 29.9조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:58 | — | NAVER | 2,025 | Q3 | CFS | BS | 유동자산 | current_assets | 10.8조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:54 | — | 삼성전자 | 2,025 | Q3 | OFS | BS | 비유동자산 | non_current_assets | 246.6조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | Q3 | OFS | BS | 자본총계 | total_equity | 10.4조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:05 | — | 신한지주 | 2,025 | Q3 | CFS | IS | 당기순이익(손실) | net_income | 1.4조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 자산총계 | total_assets | 20.6조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:54 | — | 삼성전자 | 2,025 | Q3 | OFS | BS | 유동자산 | current_assets | 78.8조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | IS | 영업이익 | operating_income | 1695.8억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:11:54 | — | 삼성전자 | 2,025 | Q3 | CFS | IS | 총포괄손익 | comprehensive_income | 20.1조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | IS | 총포괄손익 | comprehensive_income | 2201억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | IS | 당기순이익(손실) | net_income | 2198.4억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | IS | 법인세차감전 순이익 | pretax_income | 2530.8억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:05 | — | 신한지주 | 2,025 | Q3 | CFS | IS | 이자수익 | — | 6.9조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:06 | — | 삼성바이오로직스 | 2,025 | Q3 | OFS | IS | 매출액 | revenue | 1.2조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | IS | 매출액 | revenue | 6304.5억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 자본총계 | total_equity | 17.3조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:05 | — | 신한지주 | 2,025 | Q3 | CFS | IS | 순수수료손익 | — | 7680.6억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 이익잉여금 | retained_earnings | 4.8조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 자본금 | capital_stock | 2393.3억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 부채총계 | total_liabilities | 3.2조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:05 | — | 신한지주 | 2,025 | Q3 | OFS | BS | 이익잉여금 | retained_earnings | 8.2조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 비유동부채 | non_current_liabilities | 1002.3억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 유동부채 | current_liabilities | 3.1조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 비유동자산 | non_current_assets | 15조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:05 | — | 신한지주 | 2,025 | Q3 | OFS | BS | 당기손익-공정가치측정금융자산 | — | 3.5조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | OFS | BS | 유동자산 | current_assets | 5.6조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | CFS | IS | 총포괄손익 | comprehensive_income | 4246.4억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | CFS | IS | 당기순이익(손실) | net_income | 3319.2억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:05 | — | 신한지주 | 2,025 | Q3 | OFS | IS | 영업이익(손실) | — | -467.1억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | CFS | IS | 법인세차감전 순이익 | pretax_income | 3779.4억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | CFS | IS | 영업이익 | operating_income | 3014.1억원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | CFS | IS | 매출액 | revenue | 1조원 | 2025-09-30 |
| dart-financials | 2025-11-14 | 2026-07-23 20:12:01 | — | 셀트리온 | 2,025 | Q3 | CFS | BS | 자본총계 | total_equity | 16.8조원 | 2025-09-30 |